31 Oct 2022
Dr. Giordano meets Speaker Nancy Pelosi, De Laurentiis & Petrone at the 47th anniversary of NIAF
Professor Antonio Giordano founder of Sbarro Health Research Organization (SHRO) meet...
28 Oct 2022
Cellular Cilium an Early Sign of Mesothelioma Differentiation
As Published on Newswise — A new study investigated the expression...
12 Oct 2022
Adverse Events Linked to PD-1 Blockade in Some Lung Cancer Patients
Original Newswise post Newswise — Treatments with PD-1/PD-L1 immuno-checkpoint inhibitors...
26 Sep 2022
Among the causes of type 1 diabetes is a newly discovered bacterium
Analyzing the inflammatory profile of 54 patients who underwent biopsy,...
15 Sep 2022
Predicting Outcomes for Rare Form of Bladder Cancer with Metastatic Tumors
Original Newswise post Newswise — A team of investigators from...
31 Aug 2022
Molecular Medicine Review Reveals the Role of IGF in Cancer, Other Proliferative Disease
Newswise — Studies suggest that Insulin-Like Growth Factor (IGF) plays...
18 Aug 2022
Immunotherapy Covered in Special Edition of Current Clinical Pathology
Newswise — In the latest Current Clinical Pathology publication on...
18 Jul 2022
‘One Health’ Approach Is Necessary to Address Rising Environmental Causes of Childhood Cancers
Editorial by Prof. Philip Landrigan, Director of the Global Public Health...
9 Jul 2022
VR-Integrated Rehab for Cancer Patients Shows Potential in Research Review
Newswise press release — Oncology researchers using Virtual Reality (VR) in the treatment...
30 Jun 2022
(SHRO) Drug Repurposing Identifies New Candidates to Treat Mesothelioma
Newswise — A group of researchers including Antonio Giordano, M.D., Ph.D., Director and...
28 Jun 2022
Treatment with Cell Cycle Inhibitors: Another Caveat on a Clinical Trial for Mesothelioma Red-Flagged in Lancet Oncology
Original Newswise post There is a growing awareness that the...
20 Jun 2022
Sbarro Health Research Organization (SHRO) Arrives in Campania
“If I have seen further it is by standing on...